The NCI encourages innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response. This initiative will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first in human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this initiative.

• Release Date: August 13, 2009
• Application Receipt Date(s): Standard dates
• No set-aside
• Contact: Keyvan Farahani, Ph.D. (farahank@mail.nih.gov) at 301-451-2651

See full description in NIH Guide: PA-09-253